DYNLL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.409200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.855200E-01
Normal-vs-Stage2
5.318800E-01
Normal-vs-Stage3
9.363400E-03
Normal-vs-Stage4
9.293800E-01
Stage1-vs-Stage2
6.048300E-02
Stage1-vs-Stage3
1.145610E-02
Stage1-vs-Stage4
5.673000E-01
Stage2-vs-Stage3
1.50257000000042E-05
Stage2-vs-Stage4
4.170400E-01
Stage3-vs-Stage4
2.704600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.666800E-01
Normal-vs-AfricanAmerican
9.893600E-01
Normal-vs-Asian
3.116000E-01
Caucasian-vs-AfricanAmerican
6.648200E-01
Caucasian-vs-Asian
2.097400E-01
AfricanAmerican-vs-Asian
1.942980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.417600E-01
Normal-vs-Female
7.456800E-01
Male-vs-Female
9.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.917600E-01
Normal-vs-Age(41-60Yrs)
9.973200E-01
Normal-vs-Age(61-80Yrs)
6.590600E-01
Normal-vs-Age(81-100Yrs)
2.144400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.029200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.163000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.472000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.642300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.109700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.136000E-01
Normal-vs-Daily Drinker
2.586000E-01
Normal-vs-Weekly Drinker
4.461800E-01
Normal-vs-Occasional Drinker
7.974400E-01
Normal-vs-Social Drinker
8.082000E-01
Non Drinker-vs-Daily Drinker
6.995000E-01
Non Drinker-vs-Weekly Drinker
9.684400E-01
Non Drinker-vs-Occasional Drinker
1.157640E-01
Non Drinker-vs-Social Drinker
5.520500E-02
Daily Drinker-vs-Weekly Drinker
7.807600E-01
Daily Drinker-vs-Occasional Drinker
7.692000E-02
Daily Drinker-vs-Social Drinker
2.770200E-02
Weekly Drinker-vs-Occasional Drinker
1.408240E-01
Weekly Drinker-vs-Social Drinker
1.167350E-01
Occasional Drinker-vs-Social Drinker
8.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.215800E-01
Normal-vs-Grade 2
1.289650E-02
Normal-vs-Grade 3
4.395400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.037040E-01
Grade 1-vs-Grade 3
3.992800E-01
Grade 1-vs-Grade 4
1.215800E-01
Grade 2-vs-Grade 3
7.189700E-02
Grade 2-vs-Grade 4
1.289650E-02
Grade 3-vs-Grade 4
4.395400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.529600E-01
Normal-vs-NonDiabetic
7.793200E-01
Diabetic-vs-NonDiabetic
4.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.020000E-01
Normal-vs-NoPancreatitis
7.377200E-01
Pancreatitis-vs-NoPancreatitis
8.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.707400E-01
Normal-vs-N1
5.458800E-01
N0-vs-N1
2.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.878200E-01
Normal-vs-TP53-NonMutant
8.429600E-01
TP53-Mutant-vs-TP53-NonMutant
2.525800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
